Listed

AVITA Medical, Inc.

RCELNasdaqCIK 1762303HealthcareFiscal year ends Dec 31

Reports and events: 160 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

AVITA Medical, Inc., Reports and events
FiledFormWhat it isAccession number
2023-11-0916:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-062036
2023-11-0916:07 ET10-QQuarterly reportPeriod 2023-09-300000950170-23-062024
2023-10-2316:36 ET8-K5.02 Departure or appointment of officers or directors0000950170-23-054644
2023-10-1809:07 ET8-K1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0000950170-23-053882
2023-10-0208:56 ET8-K8.01 Other events0000950170-23-050935
2023-08-1016:06 ET10-QQuarterly reportPeriod 2023-06-300000950170-23-041304
2023-08-1016:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0000950170-23-041292
2023-06-2608:11 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-174497
2023-06-1619:51 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-168182
2023-06-0713:29 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-23-162334
2023-05-1620:43 ET8-K/A2.02 Results of operations0001193125-23-145360
2023-05-1216:01 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-143451
2023-05-1116:31 ET10-QQuarterly reportPeriod 2023-03-310000950170-23-021310
2023-04-2112:14 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-109996
2023-04-1415:05 ETDEF 14AProxy statementPeriod 2023-06-060001193125-23-101939
2023-03-2716:19 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-080474
2023-03-2217:26 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-076835
2023-03-2106:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-075191
2023-03-0816:06 ET8-K8.01 Other events0001193125-23-064487
2023-03-0216:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-058123
2023-02-2316:02 ET10-KAnnual reportPeriod 2022-12-310001564590-23-002302
2023-02-1016:09 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-032567
2023-01-2019:43 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-23-011170
2022-12-2016:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-309133
2022-12-1416:06 ET8-K5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-304795
2022-11-1406:18 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-283537
2022-11-1016:33 ET10-QQuarterly reportPeriod 2022-09-300001564590-22-037402
2022-11-0916:54 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-281300
2022-10-1917:20 ETDEF 14AProxy statementPeriod 2022-12-120001193125-22-265381
2022-09-3008:54 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-254959
2022-09-2216:06 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-249166
2022-09-1309:20 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-243345
2022-09-0209:03 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-237221
2022-08-3011:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-233755
2022-08-1213:21 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-219732
2022-08-1116:12 ET10-QQuarterly reportPeriod 2022-06-300001564590-22-029124
2022-07-2216:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-200015
2022-05-1716:03 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-152986
2022-05-1216:37 ET10-QQuarterly reportPeriod 2022-03-310001564590-22-019898
2022-05-1016:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-146250
2022-04-2912:11 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-131682
2022-04-2116:40 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-113106
2022-04-0516:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-096145
2022-03-2416:06 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-083864
2022-03-0911:33 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-070216
2022-03-0410:42 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-22-065361
2022-03-0112:43 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-060645
2022-02-2416:44 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-052218
2022-02-1816:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-046587
2022-02-0320:27 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-026067

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 21:29 ET. Listed shows no prices and gives no investment advice.